BioStem Technologies, Inc. (BSEM)
BSEM Stock Price Chart
Explore BioStem Technologies, Inc. interactive price chart. Choose custom timeframes to analyze BSEM price movements and trends.
BSEM Company Profile
Discover essential business fundamentals and corporate details for BioStem Technologies, Inc. (BSEM) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
17 Mar 2015
Employees
2.00
CEO
Jason V. Matuszewski
Description
BioStem Technologies, Inc., a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases. The company is also engages in the repackaging and distribution of active pharmaceutical ingredients and other pharmaceutical compounding supplies; and develops and markets nutraceutical products under the Dr. Dave's Best and Nesvik Organics brands, as well as other non-proprietary products in the United States and internationally. The company sells products through e-commerce platforms. BioStem Technologies, Inc. was incorporated in 2006 and is based in Pompano Beach, Florida.
BSEM Financial Timeline
Browse a chronological timeline of BioStem Technologies, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 11 May 2026
Upcoming earnings on 11 May 2026
Upcoming earnings on 11 Nov 2025
Revenue estimate is $51.30M.
Earnings released on 14 Aug 2025
EPS came in at $0.11 falling short of the estimated $0.32 by -65.63%, while revenue for the quarter reached $49.30M , missing expectations by -36.97%.
Earnings released on 14 Apr 2025
EPS came in at $0.68 falling short of the estimated $1.25 by -45.60%, while revenue for the quarter reached $102.87M , beating expectations by +1.76%.
Earnings released on 13 Jan 2025
Earnings released on 12 Nov 2024
EPS came in at $0.32 falling short of the estimated $0.36 by -11.11%, while revenue for the quarter reached $82.56M , missing expectations by -4.76%.
Earnings released on 12 Aug 2024
EPS came in at $0.30 surpassing the estimated $0.12 by +150.00%, while revenue for the quarter reached $74.49M , beating expectations by +69.30%.
Earnings released on 1 Apr 2024
EPS came in at -$0.14 falling short of the estimated $0.47 by -129.79%, while revenue for the quarter reached $41.90M , beating expectations by +229.95%.
Earnings released on 18 Mar 2024
EPS came in at -$0.18 falling short of the estimated $0.47 by -139.20%, while revenue for the quarter reached $11.44M , beating expectations by +0.37%.
Earnings released on 13 Nov 2023
EPS came in at $0.03 surpassing the estimated -$0.18 by +116.67%, while revenue for the quarter reached $3.60M , missing expectations by -23.10%.
Earnings released on 2 Aug 2023
EPS came in at -$0.20 falling short of the estimated $0.02 by -1.10K%, while revenue for the quarter reached $1.07M , missing expectations by -51.44%.
Earnings released on 31 Mar 2023
EPS came in at -$0.14 falling short of the estimated -$0.05 by -171.12%, while revenue for the quarter reached $576.10K , missing expectations by -71.19%.
Earnings released on 31 Dec 2022
EPS came in at -$0.30 falling short of the estimated $0.02 by -1.58K%, while revenue for the quarter reached $793.09K , missing expectations by -33.91%.
Earnings released on 15 Nov 2022
EPS came in at -$0.14 falling short of the estimated -$0.02 by -799.74%, while revenue for the quarter reached $1.15M , missing expectations by -4.52%.
Earnings released on 22 Aug 2022
EPS came in at $0.02 , while revenue for the quarter reached $2.16M .
Earnings released on 16 May 2022
EPS came in at -$0.30 , while revenue for the quarter reached $2.78M .
Earnings released on 31 Mar 2022
EPS came in at -$0.04 , while revenue for the quarter reached $1.22M .
Earnings released on 30 Sept 2021
EPS came in at -$0.05 , while revenue for the quarter reached $1.20M .
Earnings released on 30 Jun 2021
EPS came in at -$0.03 , while revenue for the quarter reached $970.51K .
Earnings released on 31 Mar 2021
EPS came in at -$0.04 , while revenue for the quarter reached $952.51K .
Earnings released on 31 Dec 2020
EPS came in at -$0.07 , while revenue for the quarter reached $2.52M .
Earnings released on 30 Sept 2020
EPS came in at -$0.08 , while revenue for the quarter reached $467.62K .
BSEM Stock Performance
Access detailed BSEM performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.